Your browser doesn't support javascript.
loading
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials.
Boccaccino, Alessandra; Rossini, Daniele; Raimondi, Alessandra; Carullo, Martina; Lonardi, Sara; Morano, Federica; Santini, Daniele; Tomasello, Gianluca; Niger, Monica; Zaniboni, Alberto; Daniel, Francesca; Bustreo, Sara; Procaccio, Letizia; Clavarezza, Matteo; Cupini, Samanta; Libertini, Michela; Palermo, Federica; Pietrantonio, Filippo; Cremolini, Chiara.
  • Boccaccino A; Unit of Oncology, University Hospital of Pisa, Pisa, Italy and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 67, 56126, Pisa, Italy.
  • Rossini D; Unit of Oncology, University Hospital of Pisa, Pisa, Italy and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 67, 56126, Pisa, Italy.
  • Raimondi A; Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Carullo M; Unit of Oncology, University Hospital of Pisa, Pisa, Italy and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 67, 56126, Pisa, Italy.
  • Lonardi S; Medical Oncology 3, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Morano F; Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Santini D; Oncologia Medica Università Campus Biomedico, Rome, Italy and UOC Oncologia Universitaria, Sapienza University of Rome, Polo Pontino, Italy.
  • Tomasello G; Oncologia Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 28, 20122 Milano, Italy.
  • Niger M; Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Zaniboni A; Medical Oncology, Fondazione Poliambulanza, Brescia, Italy.
  • Daniel F; Medical Oncology 3, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Bustreo S; S.C. Oncologia 1 U, A.O.U. Città della Salute e della Scienza di Torino, Presidio Molinette, Italy.
  • Procaccio L; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy and Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Clavarezza M; Oncology Unit Galliera Hospital, Genoa, Italy.
  • Cupini S; Department of Oncology, Division of Medical Oncology, Azienda Toscana Nord Ovest, Livorno, Italy.
  • Libertini M; Medical Oncology, Fondazione Poliambulanza, Brescia, Italy.
  • Palermo F; Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Pietrantonio F; Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • Cremolini C; Unit of Oncology, University Hospital of Pisa, Pisa, Italy and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 67, 56126, Pisa, Italy. Electronic address: chiaracremolini@gmail.com.
Eur J Cancer ; 189: 112910, 2023 08.
Article en En | MEDLINE | ID: mdl-37301718
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article